PIK-294 has been used as PI3K inhibitor in drug combination studies and their synergy quantification using the Chou-Talalay method.
A selective PI3K inhibitor
その他の情報
| CAS | 900185-02-6 |
|---|---|
| 同義語 | HMS3244F13 | HMS3655P12 | 2-{[4-Amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]methyl}-5-methyl-3-(2-methylphenyl)quinazolin-4(3H)-one | HMS3244E14 | SW220212-1 | 4(3H)-Quinazolinone,2-[[4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin- |
| 仕様と純度 | ≥98% |
| 保管条件 | Store at -20°C |
| 入荷 | Ice chest + Ice pads |
| Product Description | PIK-294 has been used as PI3K inhibitor in drug combination studies and their synergy quantification using the Chou-Talalay method. |
| パブケム・シド | 504769905 |
| パブケム・シド・ウル | https://pubchem.ncbi.nlm.nih.gov/substance/504769905 |
| 溶解度 | DMSO 98 mg/mL Water <1 mg/mL Ethanol <1 mg/mL |
| ターゲット | PIK3CD |
| EC番号 | 110-148-9 |
| PubChem CID | 24905149 |
| 分子式 | C28H23N7O2 |
レビュー
顧客レビュー
Remind me later